Valeant responds to tax crackdown Add to ...

SHARE

Replay
BNN Video |
Show Description
Michael Pearson, Chairman & CEO, Valeant Pharmaceuticals joins BNN to respond to Eugene Melnyk's claim that Valeant looks for acquisitions to avoid paying taxes.

More from this section

Most Popular

Editor's Picks

Globe Shows »

Careers
Put your best foot forward with our expert advice